Penicillin allergy labels may fuel superbugs, study warns

NCT ID NCT07177690

Ongoing Knowledge-focused Sponsor: University of Leeds Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how having a penicillin allergy record affects treatment and antibiotic resistance in patients hospitalized with COVID-19. Many people labeled as allergic to penicillin are not truly allergic, leading to use of less effective antibiotics that can drive resistance. Researchers will compare outcomes and resistance genes in patients with and without a penicillin allergy label, and see if removing incorrect labels reduces resistance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could show that removing incorrect penicillin allergy labels reduces antibiotic resistance, leading to better treatment guidelines and fewer treatment failures.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to all settings, and the sample size is modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 drug allergy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMR ANTIMICROBIAL DRUG RESISTANCE PENICILLIN ALLERGY

Contacts and locations

Locations

Leeds Teaching Hospitals NHS trust

Leeds, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.